A new dawn for stem-cell therapy

New England Journal of Medicine

Volumn 358, Issue 9, 2008, Pages 964-

  Higgs, Douglas R ^a  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DISEASE FREE SURVIVAL; EMBRYONIC STEM CELL; FIBROBLAST; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; MALIGNANT TRANSFORMATION; NONHUMAN; ONCOGENE; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; SICKLE CELL ANEMIA; THERAPY EFFECT; ANIMAL; CYTOLOGY; DISEASE MODEL; GENETIC TRANSDUCTION; HEMATOPOIETIC STEM CELL; HISTOCOMPATIBILITY TEST; MOUSE; NUCLEAR REPROGRAMMING;

ANEMIA, SICKLE CELL; ANIMALS; DISEASE MODELS, ANIMAL; EMBRYONIC STEM CELLS; FIBROBLASTS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HISTOCOMPATIBILITY TESTING; HUMANS; MICE; NUCLEAR REPROGRAMMING; PLURIPOTENT STEM CELLS; TRANSDUCTION, GENETIC;

EID: 40049084511     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMcibr0708823     Document Type: Article

References (5)

1. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006;126:663-76.
2. Hanna J, Wernig M, Markoulaki S, et al. Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin. Science 2007;318:1920-3.
3. Jaenisch R. Human cloning - the science and ethics of nuclear transplantation. N Engl J Med 2004;351:2787-91.
4. Yu CY, Vodyanik MA, Smuga-Otto K, et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007;318:1917-20.
5. Kyba M, Perlingeiro RC, Daley GQ. HoxB4 confers definitive lymphoid-myeloid engraftment potential on embryonic stem cell and yolk sac hematopoietic progenitors. Cell 2002;109:29-37.